Nemeth v. Brenntag and Toxic Tort Causation in New York: How the Court of Appeals Raised the Bar — and How Mesothelioma Plaintiffs Still Win

For decades, New Yorkers breathed in dangers they couldn't see. Maybe you handled pipe insulation at the Brooklyn Navy Yard, sanded joint compound while renovating pre-war apartments on the Upper West Side, or dusted on talcum powder every morning without a second thought. Then, 30 or 40 years later, a doctor says the word no one wants to hear: mesothelioma. In 2022, the New York Court of Appeals made these cases harder to win. Its decision in Nemeth v. Brenntag rewrote the practical rules of toxic tort causation — and if your legal team doesn't understand what the court now demands, even a $16.5 million verdict can vanish on appeal.

This post explains what happened in Nemeth, what the ruling requires, and how mesothelioma, benzene leukemia, and other toxic exposure plaintiffs in Manhattan still build winning cases today.

What Did the Court of Appeals Decide in Nemeth v. Brenntag?

In April 2022, New York's highest court threw out a $16.5 million Manhattan asbestos-talc verdict because the plaintiff's experts never showed, in scientific terms, how much asbestos she actually inhaled. The decision is Nemeth v. Brenntag North America, 38 N.Y.3d 336 (2022), and it's now the single most important causation case in New York toxic exposure litigation.

The facts were sympathetic. Florence Nemeth used Desert Flower talcum powder daily from 1960 to 1971. Decades later, she was diagnosed with peritoneal mesothelioma — a cancer of the lining of the abdomen that, as the National Cancer Institute explains, is overwhelmingly linked to asbestos and often appears only decades after exposure. A jury in New York County Supreme Court found the talc supplier liable and awarded her family $16.5 million.

At trial, her team relied on two key experts. A geologist ran what's called a "glove box" test: he agitated a vintage sample of the powder inside a sealed chamber and counted the asbestos fibers it released into the air. A physician then testified that Mrs. Nemeth's exposure was at levels "significant" enough to cause mesothelioma.

The Court of Appeals said that wasn't enough. Fibers released in a sealed laboratory chamber don't tell a jury what a real person breathed while applying powder in her own bathroom. And calling an exposure "significant" is a conclusion, not a scientific measurement. Without some scientific expression of the dose Mrs. Nemeth actually inhaled — and proof connecting that dose to levels known to cause mesothelioma — the causation case failed as a matter of law. The court reversed the verdict and dismissed the case outright, over a forceful dissent warning that the majority was setting an almost impossible burden for victims of diseases with long latency periods.

That's the stakes in one sentence: a family litigated for years, won at trial, and walked away with nothing because the expert proof on toxic tort causation didn't satisfy the court's standard.

What Is the Parker Standard for Toxic Tort Causation in New York?

The Parker standard is New York's three-part test for proving that a toxic substance caused a plaintiff's illness, and Nemeth is best understood as a strict application of it. The test comes from Parker v. Mobil Oil Corp., 7 N.Y.3d 434 (2006), a case brought by a gas station attendant who developed leukemia after years of exposure to benzene in gasoline.

Under Parker, a plaintiff's experts must establish three things:

• The plaintiff was actually exposed to the specific toxin, such as asbestos or benzene.

• General causation — meaning the toxin is capable of causing the plaintiff's particular disease at all.

• Specific causation — meaning the plaintiff was exposed to enough of the toxin to have caused his or her disease.

General causation is rarely the battleground in asbestos cases. OSHA flatly warns that there is no safe level of asbestos exposure, and CDC researchers have documented a substantial number of malignant mesothelioma deaths in the United States. The fight is almost always over specific causation: proving that your exposure was heavy enough, long enough, or concentrated enough to have caused your cancer.

Here's the part defense lawyers don't emphasize: Parker itself is flexible. The Court of Appeals said plaintiffs don't always need a precise numerical measurement of their exposure. Experts can use mathematical modeling, estimates based on how the plaintiff worked, or comparisons to published studies of workers with similar exposures. The court reaffirmed that flexibility in later cases, including Sean R. v. BMW of North America, while rejecting shortcuts like estimating dose from the strength of an odor.

Nemeth didn't overrule any of that. What it did was close the loophole of vague adjectives. "Significant," "regular," "frequent," and "excessive" are no longer acceptable substitutes for a scientific expression of dose. The court has been active across injury law in recent years — we've covered its rulings on premises liability at golf courses and the assumption of risk doctrine in sports cases — but Nemeth stands out because it took away a completed verdict.

How Do Mesothelioma and Benzene Plaintiffs Prove Specific Causation After Nemeth?

Plaintiffs win after Nemeth by turning their exposure history into numbers — or into a rigorous scientific comparison — before trial ever starts. The disease itself hasn't changed. Mesothelioma still develops silently over decades, and NIOSH still recognizes asbestos as the driving cause. What changed is the packaging of the proof.

The strongest tool is the exposure simulation study. A certified industrial hygienist recreates the plaintiff's actual activity — mixing joint compound, blowing out brake drums, applying talc — and measures the asbestos fiber concentration in the breathing zone with air sampling equipment. That's exactly what the glove box test in Nemeth failed to do. A chamber test measures what a product can release; a simulation measures what a person in the plaintiff's position would inhale. The difference decided a $16.5 million case.

From there, experts build a cumulative dose estimate. Frequency, duration, and proximity get converted into a lifetime exposure figure, often expressed in fiber-per-cubic-centimeter years for asbestos or parts-per-million years for benzene. The final step is the comparison: the expert lines up the plaintiff's estimated dose against published epidemiological studies showing disease occurring at similar or lower levels. When the plaintiff's dose sits comfortably inside the range that the medical literature links to mesothelioma or leukemia, the Parker/Nemeth standard is satisfied.

None of this works without detailed testimony. The plaintiff, coworkers, and family members must describe how often the product was used, how close the person was, how long each session lasted, and whether visible dust hung in the air. Those everyday details are the raw inputs for the dose model, which is why an experienced firm spends hours preparing exposure testimony rather than settling for "I used it a lot."

Timing matters too. Under CPLR § 214-c, a claim for injury caused by the latent effects of exposure to a harmful substance generally must be filed within three years of when you discovered the injury — or reasonably should have discovered it. A mesothelioma diagnosis starts that clock, so the scientific workup has to begin almost immediately.

How Does Nemeth Change Litigation Strategy in Manhattan's Asbestos Court?

In practical terms, Nemeth moved the decisive battle in New York City Asbestos Litigation (NYCAL) from the courtroom to the expert file. NYCAL is the dedicated part of New York County Supreme Court at 60 Centre Street in Manhattan that handles asbestos cases, and since 2022 defense firms there have made Nemeth motions a standard weapon — moving before trial to preclude plaintiff experts or win summary judgment on the ground that the causation proof is merely qualitative. Manhattan's Appellate Division, First Department, which reviews NYCAL verdicts, has applied Nemeth to unwind other large talc awards, so the threat isn't theoretical.

Most claimants miss that NYCAL's accelerated docket for gravely ill plaintiffs cuts both ways: it can push a dying plaintiff's case to trial in a matter of months, but that same speed compresses the window to commission the simulation studies and dose reconstruction that Nemeth demands, so the science has to start the day the case is signed up.

The second strategic shift is verdict protection. Winning at trial is no longer the finish line; the record has to survive two layers of appellate review. That means getting the quantified dose testimony, the air sampling data, and the published comparison studies into evidence in admissible form — clearly, on the record, with the expert walking the jury through the math. An appellate court can't affirm proof it can't find in the transcript. We've seen in other contexts, like our breakdown of Galette v. NJ Transit, how a single appellate decision reshapes strategy for every case that follows. Nemeth is that decision for toxic exposure claims.

The same logic reaches beyond asbestos. Benzene leukemia cases, solvent exposure claims, and even landlord toxic exposure cases — like the carbon monoxide poisoning verdicts we've covered — all live under the Parker framework. And because these are catastrophic, often terminal injuries, the damages at stake are enormous; our review of what NYC personal injury cases are worth in 2025 and 2026 shows why defendants fight causation so hard. When eight-figure verdicts are on the table, a causation reversal is the defense's cheapest exit.

What Questions Do Toxic Exposure Victims Ask After Nemeth?

The most common questions we hear all come back to the same fear: does the tougher toxic tort causation standard mean my case can't be won? It doesn't — it means the case has to be built correctly from day one. Here are the answers families ask for most.

Do I need an exact measurement of my asbestos exposure to win?

No. Parker and Nemeth both say precise quantification isn't always required. What you need is some scientific expression of your exposure — a simulation study, a mathematical dose model, or a rigorous comparison to published studies of similarly exposed workers — rather than an expert simply calling the exposure "significant."

How long do I have to file a mesothelioma lawsuit in New York?

Generally, three years from the date you discovered the injury or reasonably should have discovered it, under CPLR § 214-c. Because the scientific workup takes months, you shouldn't wait — the diagnosis effectively starts both the legal clock and the evidence-building clock.

Does Nemeth apply only to asbestos and talc cases?

No. It applies to every toxic exposure case in New York — benzene, solvents, lead, contaminated water, and more. Any claim that a substance caused a disease must satisfy the same three-part causation test, with a scientific expression of dose.

Can a jury verdict really be taken away on appeal?

Yes. That's exactly what happened in Nemeth: a $16.5 million Manhattan verdict was reversed and the case dismissed because the appellate record lacked quantified causation proof. Protecting a verdict means building appeal-proof science before trial, not after.

Nemeth v. Brenntag raised the bar for toxic tort causation in New York, but it didn't close the courthouse doors. Mesothelioma and toxic exposure victims still win — and still protect their verdicts on appeal — when their lawyers invest early in simulation studies, dose reconstruction, and experts who can put real numbers behind the diagnosis.

If you or someone you know has been diagnosed with mesothelioma or another illness caused by toxic exposure in New York, the team at Yassi Law PC is ready to help. Call us today at 646-992-2138 for a consultation.

Contact Us

Written by Reza Yassi

This article is for informational purposes only and does not constitute legal advice. Although I am an attorney, I am not your attorney, and reading this article does not create an attorney-client relationship. Laws vary by jurisdiction and may have changed since the publication of this article. For advice specific to your situation, consult a qualified attorney.